Helix Acquisition Corp. II
Status: Pre-Deal
U=S
IPO Proceeds, $M | $184.00M |
---|---|
IPO Date | Feb 9, 2024 |
CEO | Bihua Chen |
Left Lead | Leerink Partners |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24 months |
IPO Sector |
Healthcare
Biotechnology sector |
IPO Geography | US/Canada |
Target Company | TBD |
Deal Announced | TBD |
Deal Size, $M | TBD |
Deal Sector | TBD |
Deal Geography | TBD |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | TBD |
HLXB
Price | $10.34 |
---|---|
Last closing price | $10.24 |
H/L, today | $10.23 / $10.35 |
Volume, today | 2,577 |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Helix Acquisition Corp. II:
- Structure and cap table
- 5 directors & officers
- 5 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Bihua Chen | 55 | Chairperson and Chief Executive Officer |
Caleb Tripp | 38 | Chief Financial Officer |
Nebojsa Obradovic | 53 | Chief Legal Officer |
John Schmid | 60 | Director |
Mark McKenna | 44 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Leerink Partners | BR | 16,000,000 | units |
16,000,000 | units | ||
Up-Front UW fee | 1.00 | % | |
Deferred UW fee | 3.00 | % |
Sign in to view more advisor data.
Filings
Sign in to view 5 filings.